Literature DB >> 1548078

Identification of Candida albicans antigens reactive with immunoglobulin E antibody of human sera.

A Ishiguro1, M Homma, S Torii, K Tanaka.   

Abstract

Candida albicans antigens which reacted with immunoglobulin E (IgE) antibodies of 57 allergic patients were detected by immunoblotting. Of the various antigens, the 175-, 125-, 46-, 43-, and 37-kDa antigenic components reacted most frequently with the patient sera. To purify the major antigens, C. albicans cells were fractionated. The 46-, 43-, and 37-kDa antigens were recovered in cytoplasmic fractions, but the 175- and 125-kDa antigens were not recovered in any fraction. The 46-, 43-, and 37-kDa antigens were purified from cytoplasmic fractions by DEAE and P11 ion-exchange chromatography. Antigens were isolated by cutting bands out of sodium dodecyl sulfate-polyacrylamide gels. The purified components confirmed by immunoblotting were next processed for amino acid sequencing. Parts of the sequences of the 46-, 43-, and 37-kDa antigens had significant levels of homology with Saccharomyces cerevisiae glycolytic enzyme enolase, phosphoglycerate kinase, and aldolase, respectively. Rabbit IgG antibodies prepared against the 46- and 43-kDa antigens strongly cross-reacted with the homologous proteins of S. cerevisiae. However, S. cerevisiae enolase and phosphoglycerate kinase did not cross-react with IgE of patient sera. This result suggests that IgE antibodies against only small parts of their epitopes are elevated in the allergic patients. Since enolase is reported to be a major antigen for systemic candidiasis, this enzyme may be the immunodominant protein in both allergies and fungal infections.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1548078      PMCID: PMC257030          DOI: 10.1128/iai.60.4.1550-1557.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

Review 1.  Antigens and immune responses in Candida albicans infection.

Authors:  R B Ashman; J M Papadimitriou; A K Ott; J R Warmington
Journal:  Immunol Cell Biol       Date:  1990-02       Impact factor: 5.126

2.  Immunoblot analyses of Candida albicans-associated antigens and antibodies in human sera.

Authors:  M Manning-Zweerink; C S Maloney; T G Mitchell; H Weston
Journal:  J Clin Microbiol       Date:  1986-01       Impact factor: 5.948

3.  Immunoblot analysis of the serological response in systemic candidosis.

Authors:  R C Matthews; J P Burnie; S Tabaqchali
Journal:  Lancet       Date:  1984-12-22       Impact factor: 79.321

4.  A sensitive immunoblotting method for measuring protein synthesis initiation factor levels in lysates of Escherichia coli.

Authors:  J G Howe; J W Hershey
Journal:  J Biol Chem       Date:  1981-12-25       Impact factor: 5.157

5.  Distribution of watersoluble antigens and allergens of Candida albicans in blastospore cell extract fractions.

Authors:  J Savolainen; M Viander; A Koivikko
Journal:  Allergy       Date:  1990-01       Impact factor: 13.146

6.  Genetic evidence for role of extracellular proteinase in virulence of Candida albicans.

Authors:  K J Kwon-Chung; D Lehman; C Good; P T Magee
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

7.  Allergenic components of Candida albicans identified by immunoblot analysis.

Authors:  H D Shen; K B Choo; R B Tang; C F Lee; J Y Yeh; S H Han
Journal:  Clin Exp Allergy       Date:  1989-03       Impact factor: 5.018

8.  Conservation of high efficiency promoter sequences in Saccharomyces cerevisiae.

Authors:  M J Dobson; M F Tuite; N A Roberts; A J Kingsman; S M Kingsman; R E Perkins; S C Conroy; L A Fothergill
Journal:  Nucleic Acids Res       Date:  1982-04-24       Impact factor: 16.971

9.  Isolation and identification of yeast messenger ribonucleic acids coding for enolase, glyceraldehyde-3-phosphate dehydrogenase, and phosphoglycerate kinase.

Authors:  M J Holland; J P Holland
Journal:  Biochemistry       Date:  1978-11-14       Impact factor: 3.162

10.  Inhalant allergies to fungi: reactions to bakers' yeast (Saccharomyces cerevisiae) and identification of bakers' yeast enolase as an important allergen.

Authors:  B A Baldo; R S Baker
Journal:  Int Arch Allergy Appl Immunol       Date:  1988
View more
  19 in total

Review 1.  Cell wall and secreted proteins of Candida albicans: identification, function, and expression.

Authors:  W L Chaffin; J L López-Ribot; M Casanova; D Gozalbo; J P Martínez
Journal:  Microbiol Mol Biol Rev       Date:  1998-03       Impact factor: 11.056

2.  Characterization of Cannabis sativa allergens.

Authors:  Ajay P Nayak; Brett J Green; Gordon Sussman; Noam Berlin; Hemant Lata; Suman Chandra; Mahmoud A ElSohly; Justin M Hettick; Donald H Beezhold
Journal:  Ann Allergy Asthma Immunol       Date:  2013-05-22       Impact factor: 6.347

3.  The cell wall-associated glyceraldehyde-3-phosphate dehydrogenase of Candida albicans is also a fibronectin and laminin binding protein.

Authors:  D Gozalbo; I Gil-Navarro; I Azorín; J Renau-Piqueras; J P Martínez; M L Gil
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

Review 4.  Serologic response to cell wall mannoproteins and proteins of Candida albicans.

Authors:  J P Martínez; M L Gil; J L López-Ribot; W L Chaffin
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

5.  Production of a Chaetomium globosum enolase monoclonal antibody.

Authors:  Brett J Green; Ajay P Nayak; Angela R Lemons; William R Rittenour; Justin M Hettick; Donald H Beezhold
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2014-12

6.  Glycolytic enzymes of Candida albicans are nonubiquitous immunogens during candidiasis.

Authors:  R K Swoboda; G Bertram; H Hollander; D Greenspan; J S Greenspan; N A Gow; G W Gooday; A J Brown
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

7.  Genetic organization and mRNA expression of enolase genes of Candida albicans.

Authors:  P Postlethwait; P Sundstrom
Journal:  J Bacteriol       Date:  1995-04       Impact factor: 3.490

Review 8.  T helper cell dichotomy to Candida albicans: implications for pathology, therapy, and vaccine design.

Authors:  L Romani; E Cenci; A Menacci; F Bistoni; P Puccetti
Journal:  Immunol Res       Date:  1995       Impact factor: 2.829

9.  Exogenous farnesol interferes with the normal progression of cytokine expression during candidiasis in a mouse model.

Authors:  Dhammika H M L P Navarathna; Kenneth W Nickerson; Gerald E Duhamel; Thomas R Jerrels; Thomas M Petro
Journal:  Infect Immun       Date:  2007-05-21       Impact factor: 3.441

Review 10.  Atopic dermatitis and fungi.

Authors:  Jan Faergemann
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.